Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03995628 · ClinicalTrials.gov registry record · Phase 2
Steroids and Pain Control After Tonsillectomy
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 163
- Enrollment target
NCT03995628 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 163 participants.
The verdict
NCT03995628, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 163 participants
- Enrollment target
Study Summary
This research study aims to find out if a single oral dose of steroid after tonsillectomy will reduce pain and decrease the need for narcotic medications.
Interventions
- DRUG Placebo
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03995628
The ClinicalTrials.gov registry entry for NCT03995628 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03995628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03995628 about?
NCT03995628 is a clinical study titled "Steroids and Pain Control After Tonsillectomy". This research study aims to find out if a single oral dose of steroid after tonsillectomy will reduce pain and decrease the need for narcotic medications.
What is the current status of trial NCT03995628?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 163 participants. The study started on 2018-12-18. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT03995628?
The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03995628?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.